I asked ChatGPT for the best FTSE 100 shares to consider for 2026, and it said…

Whatever an individual investor’s favourite strategy, I reckon there’s something for everyone among the shares in the FTSE 100.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ChatGPT’s found me some popular FTSE 100 shares to mull going into the New Year. But I think some would put me on the road to nowhere. So I’ve had to use my human brain to barrow down my search criteria and pick candidates in three different categories.

Looking for relatively safe blue-chips, pharmaceutical giant AstraZeneca (LSE: AZN) is one I’ll definitely look at. AstraZeneca has a forward price-to-earnings (P/E) ratio of 27, with the share price having soared 90% in the past five years. With a forecast dividend yield of just 1.7%, it might not look great value, but as defensive stocks go, it has to be a consideration.

With the latest update in November, CEO Pascal Soriot spoke of “an unprecedented 16 positive Phase III trials this year, with four since our previous results including high-impact readouts for baxdrostat in hypertension and Enhertu and Datroway in breast cancer.

He also pointed to expansion in the US, with construction of the company’s new $4.5bn manufacturing facility in Virginia already commenced. These highlight the key strengths for me. AstraZeneca’s share valuation might be the biggest danger, especially if investors move away from safety in 2026. But its very strong pipeline and global market reach lead me to rate it a definite long-term consideration.

FTSE 100 growth

The FTSE 100 isn’t really home to many growth candidates, but Rio Tinto (LSE: RIO) enjoyed a bit of cyclical growth in the latter half of 2025. And with the share price up only 7% in five years, I see a good chance of more to come.

Global demand for metals has been strong. I can see solid demand for quite some time yet, especially if China gets back into top gear. Even with a slight slowdown predicted, GDP growth for the country is expected to come in between 4% and 5% this year. Most Western economies can only dream of that.

My main concern is if precious metal fever subsides — which it surely must, right? Rio does produce some gold and silver, and it could take a hit. But it’s a major supplier of copper, aluminium and iron. And it also unearths lithium, selenium, molybdenum and many more in demand by various high-tech industries. Add in a 4.8% forecast dividend yield, and Rio Tinto has to be one to consider for 2026.

Show me the cash

For FTSE 100 income, I like the 4.7% dividend yield on the cards for Prudential (LSE: PRU). That’s higher than we were used to from the Pru of old. And it comes even after the share price has gained nearly 50% in five years. It is however, worth noting that the share price is only about where it was back in 2018.

Maybe today’s higher valuation could weigh against the stock in the future. This is a cyclical business, after all — and a P/E of 14 might be a bit toppy for the sector.

But I reckon Prudential’s key strength lies in its Asian prospects. At Q3 time, CEO Anil Wadhwani praised the “particular focus on ASEAN markets where we see an opportunity to build on the agency new business profit growth achieved in the markets of Greater China.”

So I’m considering the Pru for my 2026 Stocks and Shares ISA.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and Prudential Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

2 stocks to buy before they bounce back in 2026?

Buying undervalued stocks is a great way to try and build wealth. But it’s even better when the companies are…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

1 of the FTSE 100’s best bargains to consider for 2026!

Royston Wild discusses a top FTSE 100 share he owns in his portfolio -- and explains why he think it's…

Read more »

British Pennies on a Pound Note
Investing Articles

On a P/E ratio of just 3, is this penny stock a deep bargain?

Christopher Ruane previously made a profit buying and later selling this penny stock. Why has he bought it again, with…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

I’ve bought this 6.6%-yielding FTSE 250 share, hoping for a 2026 price recovery

This FTSE 250 share has more than halved in the past five years. But it still offers an attractive dividend…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

A once-in-a-decade chance to buy these UK income shares cheap?

The investing focus in 2026 might just be returning to long-term income shares after a roller-coaster decade for the UK…

Read more »

A GlaxoSmithKline scientist uses a microscope
Investing Articles

Up 9.9%! Here’s why Oxford Nanopore stock topped the FTSE 250 today

This innovative company's stock price marched higher today in the FTSE 250 index. Might this be my first Stocks and…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock’s defied gravity before. Can it do it again?

Could Tesla stock really be worth close to 300 times earnings -- or more? Christopher Ruane explains his thinking about…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

As Greggs’ share price dives, is this a once-in-a-decade opportunity?

The Greggs share price looks incredibly cheap on paper. But does this represent an attractive dip-buying opportunity? Royston Wild investigates.

Read more »